NCT04662060View on ClinicalTrials.gov

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 23, 2021

Primary Completion Date

May 3, 2022

Study Completion Date

February 2, 2023

Conditions
Covid19
Interventions
DRUG

Acebilustat

100 mg capsule administered orally once daily

DRUG

Placebo

Placebo to match acebilustat administered orally once daily

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER